| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/02/2008 | WO2008117125A2 Compositions capable of facilitating penetration across a biological barrier |
| 10/02/2008 | WO2008116919A1 Pharmaceutical composition comprising a cytokine |
| 10/02/2008 | WO2008116648A2 Novel glp-1 fusion peptides, their production and use |
| 10/02/2008 | WO2008116470A1 Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor |
| 10/02/2008 | WO2008116468A2 Mhc peptide complexes and uses thereof in infectious diseases |
| 10/02/2008 | WO2008116347A1 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies |
| 10/02/2008 | WO2008116319A1 Bioproduction of ferulic acid and uses thereof |
| 10/02/2008 | WO2008116294A1 Exendin analogs |
| 10/02/2008 | WO2008116265A1 Peptides with anitfungal activity |
| 10/02/2008 | WO2008116262A1 Methods and compositions for treating prostate cancer |
| 10/02/2008 | WO2008106130A3 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| 10/02/2008 | WO2008098169A3 Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
| 10/02/2008 | WO2008090287A3 Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus |
| 10/02/2008 | WO2008086612A8 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 10/02/2008 | WO2008073463A3 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 10/02/2008 | WO2008067070A3 Compositions and methods for producing benzylisoquinolines alkaloids |
| 10/02/2008 | WO2008066603A3 S-nitrosothiol compounds and related derivatives |
| 10/02/2008 | WO2008063757A3 Use of tight junction agonists for modulation of the blood brain barrier |
| 10/02/2008 | WO2008063676A3 Treatment of injury to the brain by inhibition of acid sensing ion channels |
| 10/02/2008 | WO2008063291A3 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 10/02/2008 | WO2008059222A3 Animal feeds and veterinary compositions |
| 10/02/2008 | WO2008051505A8 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 10/02/2008 | WO2008050161A3 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds |
| 10/02/2008 | WO2008048472A3 Methods and compositions for stabilizing prostate specific antigen |
| 10/02/2008 | WO2008035093A3 Peptides |
| 10/02/2008 | WO2008032054A3 Composite material comprising a tissue matrix compound and a bioactive glass |
| 10/02/2008 | WO2008021577A3 Polymerized hemoglobin media and its use in isolation and transplantation of islet cells |
| 10/02/2008 | WO2008020260A3 Use of siderophores in prevention of vascular diseases, production of siderophores and qualifying siderophore containing meat-products |
| 10/02/2008 | WO2008018854A3 Bactiophage lysins for bacillus anthracis |
| 10/02/2008 | WO2008013996A3 Engineered microorganisms for increasing product yield in biotransformations, related methods and systems |
| 10/02/2008 | WO2007149287A3 Transfer factor compositions and methods |
| 10/02/2008 | WO2007145840A3 Compositions and methods for diagnosing and treating cancer |
| 10/02/2008 | WO2007142757A3 Compositions and methods for affecting movement of contaminants, bodily fluids or other entities and/or affecting other physiological conditions |
| 10/02/2008 | WO2007134229A3 Fungus-specific imaging agents |
| 10/02/2008 | WO2007130575A3 Protection against oxidative damage in cells |
| 10/02/2008 | WO2007128545A9 Mac30 gene |
| 10/02/2008 | WO2007127136A3 Antibiotic compounds |
| 10/02/2008 | WO2007126938A3 Marker for chromosomal abnormalities |
| 10/02/2008 | WO2007120504A3 Targeted charge-reversal nanoparticles for nuclear drug delivery |
| 10/02/2008 | WO2007095287A3 Protective complement proteins and age-related macular degeneration |
| 10/02/2008 | WO2007093806A8 Dissolution aids for oral peptide delivery comprising a biguanide |
| 10/02/2008 | WO2007073509A8 Modified annexin proteins and methods for their use in organ transplantation |
| 10/02/2008 | WO2007019545A3 Tissue protective peptides and uses thereof |
| 10/02/2008 | WO2006093973A3 Biomarkers of vulnerable a therosclerotic plaques and methods of use |
| 10/02/2008 | WO2006074178A3 Alkyl phosphine detergent products and extraction processes |
| 10/02/2008 | WO2005124563A3 Compounds and kits for treating muscle disorders and methods of use thereof |
| 10/02/2008 | US20080242846 O-linked glycosylation of peptides |
| 10/02/2008 | US20080242843 Function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 10/02/2008 | US20080242841 Methods of modulating cold sensory perception |
| 10/02/2008 | US20080242840 Saposin B specific monoclonal antibody for use in treatment and prevention of cell proliferative disorders |
| 10/02/2008 | US20080242839 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 10/02/2008 | US20080242629 Hybrid nucleic acids; controlling gene expression; metabolism disorders, obesity, diabetes |
| 10/02/2008 | US20080242628 In vivo |
| 10/02/2008 | US20080242623 Microutrophin and Uses Thereof |
| 10/02/2008 | US20080242621 Reducing blood glucose; increase insulin sensitivity; antidiabetic agents |
| 10/02/2008 | US20080242620 Stimulation T-cell transformation; cell proliferation disorders; anticancer agents; antiscarcoma; mixture of tripeptide and carrier ; nutrient |
| 10/02/2008 | US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders |
| 10/02/2008 | US20080242618 Stratification |
| 10/02/2008 | US20080242617 Two component bacillus lantibiotic and methods for producing and using the same |
| 10/02/2008 | US20080242616 Peptide specificity of anti-myelin basis protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 10/02/2008 | US20080242615 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 10/02/2008 | US20080242614 Polypeptide containing valine or proline; therapy for infections |
| 10/02/2008 | US20080242613 Protease activated receptors; angiogenesis inhibitor; cardiovascular disorders |
| 10/02/2008 | US20080242612 Suspension containing milk fat spheres; therapy for infant weight disease |
| 10/02/2008 | US20080242611 Administering transforming growth factor polypeptide along with cytotoxic agent |
| 10/02/2008 | US20080242610 Anticarcinogenic agents; polypeptide including ligand that stimulants natural killer receptor and intracytoplasmic death domain |
| 10/02/2008 | US20080242609 Composition for the therapy of diabetes mellitus and adiposity |
| 10/02/2008 | US20080242608 Prevent apoptosis; reduce concentration of isomerase;Alzheimer's disease, Parkinson's disease, Huntington's disease; brain disorders , strokes, multiple sclerosis, antiischemic agents |
| 10/02/2008 | US20080242607 Glycosylation of peptides via o-linked glycosylation sequences |
| 10/02/2008 | US20080242606 Calibrate sensitivity to metastasis; antitumor agents;anticancer agents; kidney and bladder cancer; quantitative immunohistochemistry |
| 10/02/2008 | US20080242605 Prevent binding of formyl methionine-leucine-phenylalanine and, or protein to granulocytes; antiinflammatory agents; viricides; HIV infections |
| 10/02/2008 | US20080242604 Nucleotide sequence coding protein; for therapy of periodontal disease; wound healing agent |
| 10/02/2008 | US20080242603 Interleukins; genetic engineering; vectors and host cells; anticancer agents; immunology diseases; infections; antiischemic agents; antitumor agents |
| 10/02/2008 | US20080242602 Methods and Compositions For the Inhibition of Hiv-1 Replication |
| 10/02/2008 | US20080242601 Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization |
| 10/02/2008 | US20080242600 Oral bioavailability; intestine permeability; metabolism disorders such as obesity |
| 10/02/2008 | US20080242599 Compositions and Methods for Increasing Osteoblast Cell Differentiation and Bone Generation |
| 10/02/2008 | US20080242598 Short chain peptide; conformation scaffolds; diecting amino acids into positions; controlling apoptosis; tumor suppression; alcoholism; drug abuse; antiepileptic agents |
| 10/02/2008 | US20080242597 Antibiotic compounds |
| 10/02/2008 | US20080242596 Such as 2-(2-(allyloxymethyl)-4-chloro-5-(4-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; sodium dependent glucose cotransporter inhibitors; type 1 or type 2 diabetes and related disorders; combination formulations |
| 10/02/2008 | US20080242595 Conjugate of insulin and vitamin B12 for oral delivery |
| 10/02/2008 | US20080242594 Contacting neuronal precursor cells with notch ligand and janus kinase and/or p38 inhibitor; isolated population of cells expressing nestin and STAT3 having phosphorylated serine 727 |
| 10/02/2008 | US20080242593 Such as 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(6-(2-ethylphenyl)pyridin-3-yl)propanoic acid; stability to proteolytic cleavage |
| 10/02/2008 | US20080242592 Administering dried plum solids with flavonoids, hydroxycinnamic acid, and a fiber component of soluble fiber, and a soluble, indigestible oligosaccharide |
| 10/02/2008 | US20080242591 Treating vascular malformation with nicotinic acetylcholine receptor (nAChR) antagonist; arthritis, cancer |
| 10/02/2008 | US20080242590 New Method 706 |
| 10/02/2008 | US20080242589 Synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 10/02/2008 | US20080242588 Inhibiting acid sensing ion channel 1a (ASIC1a); epilepsy; using PcTX1 or peptide derivative and/or amiloride or derivative |
| 10/02/2008 | US20080242587 Including nucleotide sequence encoding Tie2 and vascular endothelial growth factor receptor (VEGF) components; edema and tumor growth prevention |
| 10/02/2008 | US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same |
| 10/02/2008 | US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders |
| 10/02/2008 | US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 10/02/2008 | US20080241924 Using cell adhesion molecule specific immunoglobulin for prevention and treatment of colon, breast and cervical cancers |
| 10/02/2008 | US20080241884 Fused Protein Composition |
| 10/02/2008 | US20080241882 Nucleotide sequences coding cell growth factor for use in diagnosis, prevention and treatment of nervous system disorders |
| 10/02/2008 | US20080241872 Using cold and menthol-sensitive receptor (CMR1) polypeptide as diagnostic tool in identifying modulators for treatment of pain and cold sensitivity |
| 10/02/2008 | US20080241861 Biological materials and methods useful in the diagnosis and treatment of diseases |
| 10/02/2008 | US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases |
| 10/02/2008 | US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 10/02/2008 | US20080241825 Materials and Methods for Treatment of Cancer |